Are cirrhosis patients getting the shots they need? french study finds out

NCT ID NCT04939350

Completed Knowledge-focused Sponsor: Centre Hospitalier Sud Francilien Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how many people with cirrhosis in French general hospitals were vaccinated against diseases like hepatitis, flu, and COVID-19. Researchers surveyed 742 patients to see if they were up to date on their shots. The goal was to find gaps in vaccination coverage so doctors can better protect this vulnerable group.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could highlight where vaccination efforts need improvement for people with cirrhosis, potentially leading to better protection guidelines.
What could go wrong: This is an observational study, not a treatment trial. It only measures current vaccination rates and does not test any new intervention or directly improve health.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CIRRHOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cirrhosis of liver Fibrosis hepatitis A virus infection hepatitis B virus infection poliomyelitis tetanus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CIRRHOSIS

Contacts and locations

Show contact details

Locations

Centre Hospitalier Sud Francilien

Corbeil-Essonnes, France, 91106, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.